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Type 2 diabetes mellitus is a metabolic disorder that is 
characterized by high blood glucose due to either insulin 
resistance or insulin deficiency [1]. A direct correlation 
between D-glucose and diabetic complications has long 
been established, and is the focus of most research in this 
field. In contrast, D-Ribose has been overlooked so far as a 
potential risk player in the development of diabetes. 
Recently published reports found abnormally high levels 
of D-ribose in the urine of diabetic patients [2]. Elsewhere, 
intravenous administration of D-ribose resulted in a de-
crease in blood D-glucose, concomitantly with an increase 
in the level of glycated serum proteins [3]. It is known that 
administration of high dose of D-ribose rapidly glycates 
proteins in vivo and in vitro [46], which results in the pro-
duction of high levels of advanced glycation end products. 
D-glucose, in contrast, cannot be used to the same effect, 
even under identical conditions [7]. 
Therefore, as we hypothesized, dysfunction of the me-
tabolism of D-ribose may play a role involving the devel-
opment of complications of type 2 diabetes mellitus, and it 
is feasible that D-ribose could be used as a biomarker for 
type 2 diabetes mellitus. That is, diabetics suffer from dys-
function of energy metabolism, involving not only D-  
glucose, but also D-ribose. This viewpoint for D-ribose in 
diabetes is based on these observations: (i) Diabetics display 
abnormal increases in the level of uric D-ribose; (ii) Raised 
levels of D-ribose result in increased ribosylation activity, 
in the result of which more advanced glycation end products 
accumulate in cells; and (iii) D-ribose could be used as a  
new biomarker for type 2 diabetes mellitus, as it is easily 
measured in the urine of diabetic patients. 
We suggest that this novel view of type 2 diabetes melli-
tus deserves further and detailed investigation, both at the 
level of basic and clinical research, to clarify whether and 
how D-ribose and its metabolism are related with diabetic 
complications. 
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